Top News Stories
News
But wait, there's more: VK2735 may beat current obesity drugs
By Allison BellViking Therapeutics' dual-action contender could add to pharmacy benefits cost pressure.
Viking Therapeutics' dual-action contender could add to pharmacy benefits cost pressure.